Present paper deals with the synthesis, spectral characterization and X-ray diffraction study of Zn(II) complex with Pioglitazone a new oral antidiabetic drug. The conductometric titration using monovariation method indicate that complex is ionic and L 2
INTRODUCTION
Pioglitazone HCl (PLZ) Fig.1 , ((±) 5 {p [2 (5 ethyl 2 pyridyl)ethoxy] benzyl} 2, 4 thiazolidinedione hydrochloride) is an oral antidiabetic agent used in the treatment of type 2 diabetes mellitus also known as non insulin dependent diabetes mellitus 1 (NIDDM) or adult onset diabetes. Pioglitazone decrease insulin resistance in the periphery and liver, resulting in increased insulin dependent glucose disposal and decreased hepatic glucose output. Currently, it is marketed under the trade name Actos® 2 . It is a white or almost white crystalline, odourless powder, practically tasteless, insoluble in water and alcohols, 1 H NMR, Mass and X-ray diffraction.
but soluble in 0.1 N NaOH; it is freely soluble in dimethylformamide. It exhibits slow gastrointestinal absorption rate and inter individual variation of its bioavailability 3 . A survey of literature reveals that metal complexes of many drugs have been found to be more effective than the drug alone 4 therefore, much attention is given to the use of thiazolidinedione hydrochloride due to their high complexing nature with essential metals. Fig.2 shows the enolization nature of complex formation . Zinc is an essential trace metal, so we get it through the food we eat. Next to iron, zinc is most common mineral in the body and is found in every plant and animal cell. 5 It has been used since ancient times to heal wounds and plays an important role in the immune system, reproduction, growth, vision, blood clotting, proper insulin and thyroid function [6] [7] Chelates of streptomycin are obtained by adding aqueous solutions of zinc salts to the solution of streptomycin at pH 9.0 (loc.cit). Zinc complex of sulpha drugs have been prepared and studied by Salil et al., 8 Bipin et al., 9 Sharma et al., 10 Iqbal and co-workers [11] [12] [13] and compare the antidiabetic properties of zinc complex with the parent drugs. 
EXPERIMENTAL

Ligand-Metal ratio
To confir m the ligand metal ratio, conductometric titration using monovariation method were carried out at 27 ±1 ºC, 0.005M solution of pioglitazone HCl drug was prepared in DMF. Similarly, solution of metal salt ZnCl 2 was prepared in the ethanol of 0.01M concentration. 20ml of ligand was diluted to 200ml with the same solvent. The ligand was titrated against metal salt solution using monovariation method. Conductance was recorded after each addition, graph is plotted between corrected conductance and volume of metal salt added. From the equivalence point in the graph it has been concluded that the complex formation has taken place in the ratio of 2:1 (L 2 M). Stability constant and free energy change were also calculated using Job's method 14 
Synthesis of Complex
A weighed quantity of "Pioglitazone" (2 mol) was dissolved separately in minimum quantity of DMF. Zinc solution was prepared by dissolving separately in the ethanol. Ligand solution was added slowly with stirring into the solution of metallic salt at room temperature; maintain the pH between 6.0 to 6.5 by adding dilute NaOH solution. On refluxing the mixture for 3-4 h at 70 o C and on cooling, white colored crystals were obtained which were filtered off, washed well with DMF and finally dried in vacuum and weighed (yield 51.08%).
Instrumentation
Molar conductance of solid complex in DMF was measured by using Systronics Digital Conductivity meter. Melting point was determined by Perkin Elmer model melting point apparatus and is uncorrected. The elemental analysis of the isolated complex was carried out by using Coleman analyzer model at the Departmental Micro Analytical Laboratory, CDRI, Lucknow, India. IR spectra of ligand and complex were recorded with Perkin Elemer Model 577 Spectrophotometer in the range of 4000-450 cm -1 as KBr pellets CDRI, Lucknow, India.
1 H NMR spectra of the ligand and isolated complex were recorded on a Bruker DRX-300 Spectrophotometer and d 6 -DMSO was used as solvent CDRI, Lucknow, India. X-ray diffraction studies were carried out by X-ray diffractometer model with 45kV rotating anode and Cuk ± (1W=1.54060A°) radiation at Punjab University, Chandigarh, India.
Mass spectra of zinc complex was recorded at CDRI, Lucknow, India which provides information about the complex by examining the fragmentation pattern and total mass of the complex. Proposed structure for the isolated complex (Fig.-4) are also supported by mass spectral studies of Mc Cullagh et al., 16 Bayliss and Lashin., 17 Windig et al., 18 Andrew., 19 Mc Lafferty, 20 Iqbal et al., 21 . 
RESULTS AND DISCUSSION
P h y s i c o -c h e m i c a l C h a r a c t e r s t i c s o f "Pioglitazone"-Zinc complex
Infra-red Spectral Studies
The IR spectrum [22] [23] [24] of isolated complex were recorded within the range 4000-400 cm -1 . Assignments of the infrared spectral bands are based on literature. IR spectrum of PLZ-Zn complex (Fig. 4) shows important bands due to ν(M-O) 509±10 cm 34 Budhani et al., 35 .
Mass Spectral studies
Mass spectra represents the intensities of signals at various m/z values. It is highly characteristic , m/z 134 due to [C 8 H 18 N] +. radical ion.
X-Ray Diffraction Studies
X-ray diffraction studies also confirm the complex formation due to new bonds. [36] [37] [38] [39] [40] . The number of peaks in Pioglitazone are more as compared to their zinc complex Fig.6 (a, b) which shows the formation of complex. Moreover, all the reflections are new ones and the patterns are fairly strong. On comparing the pattern obtained with available literature, it is evident that its pattern is not in good agreement with available information and thus confirms the formation of totally new complex . The X-ray pattern have been indexed by using computer software (FPSUIT 2.0V) and applying interactive trial and error method keeping in mind the characteristics of the various symmetry system, till a good fit was obtained between the observed and the calculated Sin 2¸ value. The unit cell parameters were calculated from the indexed data, cell data and crystal lattice parameters, Zn(II) indicates complex attributed to orthorhombic crystal system. The particle size is 19.16 microns of "Pioglitazone"-zinc complex respectively, which is calculated from x-ray line broadening using the Scherrer formula Dhkl =º»/²hkl cos¸, where D is the particle diameter in A° , º is a coefficient and is equal to 0.89 here, ² is the half-maximum line width, and » is the wavelength of x-rays, porosity is 0.10% calculated by formula and volume of the unit cell is 14016.31 A° calculated by Volume(Å), = abc where a, b and c are lattice parameters . Density = is found 0.0607 gcm -3 for "Pioglitazone"-zinc complex respectively. Space group is Pmmm and α=90°, β=90°, γ =90°. Zn]2Cl -. For the complexation of "Pioglitazone" with zinc, it was concluded that the "Pioglitazone" undergoes enolization before complexation so as to form a hexacyclic hetrocyclic chelate ring. The formation of complex through enolization is also supported from the frequency of IR, ¹H NMR and Mass spectral studies. Molar Conductance values of complex support the ionic structure of the complex. The thiazolidinedione unit inside the coordination sphere has a positive charge while Cl -occupies the outer place of the coordination sphere. A detailed study of X-Ray also supports the complex formation and the various values like particle size, porosity, volume of unit cell, density as well as crystal system was evaluated and discussed.
